Approval · Notice of Compliance 31012 · 2023
NUWIQ: Notice of Compliance 31012
Issued June 16, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 31012
- Date
- June 16, 2023
- Company
- Octapharma Pharmazeutika Produktionsges M B HVienna, Vienne, Austria
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Product Monograph update
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NUWIQ | Not yet assigned | — |
Medicinal ingredients
- SIMOCTOCOG ALFA 250 UNIT per VIAL
- SIMOCTOCOG ALFA 500 UNIT per VIAL
- SIMOCTOCOG ALFA 1,000 UNIT per VIAL
- SIMOCTOCOG ALFA 2,000 UNIT per VIAL
- SIMOCTOCOG ALFA 2,500 UNIT per VIAL
- SIMOCTOCOG ALFA 3,000 UNIT per VIAL
- SIMOCTOCOG ALFA 4,000 UNIT per VIAL
- SIMOCTOCOG ALFA 1,500 UNIT per VIAL